Literature DB >> 3008568

Inhibition of hepatic glucose production by insulin in vivo in rats: contribution of glycolysis.

J Terrettaz, F Assimacopoulos-Jeannet, B Jeanrenaud.   

Abstract

The action of insulin on hepatic glucose production (HGP) has been studied in fed anesthetized rats during a euglycemic hyperinsulinemic clamp. At the end of the clamp, the liver was rapidly removed, frozen, and enzyme activities and metabolites were measured. When insulin totally suppressed HGP, it did not modify glycogen phosphorylase or synthase activity, nor did it "spare" or increase glycogen content. Insulin decreased glucose 6-phosphate while increasing glycolytic intermediates (fructose 1,6-bisphosphate, alpha-glycerophosphate, lactate, and pyruvate) as well as fructose 2,6-bisphosphate, the potent effector of 6-phosphofructo-1-kinase. Insulin also increased pyruvate kinase activity of low substrate concentration. Lipogenesis measured with 3H2O incorporation into fatty acids was increased four-to fivefold by insulin. The data suggest that in normal rat liver, when glycemia is maintained at constant basal level, insulin promotes no change in glycogen metabolism, whereas the hormone stimulates the glycolytic pathway. This action contributes to the suppression of hepatic glucose production observed after the addition of the hormone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008568     DOI: 10.1152/ajpendo.1986.250.4.E346

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

Review 1.  Fuel selection and carbon flux during the starved-to-fed transition.

Authors:  M C Sugden; M J Holness; T N Palmer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Authors:  K F Petersen; D Laurent; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

3.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

4.  The onset of liver glycogen synthesis in fasted-refed lean and genetically obese (fa/fa) rats.

Authors:  G van de Werve; B Jeanrenaud
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 5.  Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues.

Authors:  L Hue; M H Rider
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

Review 6.  An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

7.  Contribution of glycerol and alanine to basal hepatic glucose production in the genetically obese (fa/fa) rat.

Authors:  J Terrettaz; B Jeanrenaud
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

8.  Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats.

Authors:  S Halimi; F Assimacopoulos-Jeannet; J Terrettaz; B Jeanrenaud
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

9.  Development of insulin-sensitivity at weaning in the rat. Role of the nutritional transition.

Authors:  T Issad; C Coupé; M Pastor-Anglada; P Ferré; J Girard
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

10.  Decrease in serum matrix metalloproteinase-9 and matrix metalloproteinase-3 levels in Zucker fa/fa obese rats after treatment with swertiamarin.

Authors:  Hb Vaidya; S Giri; M Jain; Rk Goyal
Journal:  Exp Clin Cardiol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.